HDCN Abstract:  ASN Annual Meeting 2020 -- Digital Meeting  

Ethier I, Cho YJ, Hawley C, et al.

Rate of Decline in Residual Kidney Function Before and After Peritoneal Dialysis Initiation: A Post Hoc Analysis of the IDEAL Study

ASN Annual Meeting 2020 -- Digital Meeting
J Am Soc Nephrol (Oct) 31:50A 2020

BACKGROUND

Residual kidney function (RKF) is associated with improved survival and quality of life in dialysis patients. Previous studies have suggested that commencement of peritoneal dialysis (PD) may slow RKF decline compared to the pre-dialysis period. We sought to evaluate the association between PD initiation and RKF decline in the Initiating Dialysis Early And Late (IDEAL) trial.

METHODS

In this post hoc analysis of the IDEAL randomized controlled trial, PD participants were included if results from 24-hour urine collections had been recorded within 30 days of dialysis initiation (-30 to +30 days from start), and at least one value pre- and one value post-dialysis commencement were available. The primary outcome was slope of RKF decline, calculated as mean of urinary creatinine and urea clearances. Secondary outcomes included slope of urine volume decline and time from PD initiation to anuria.

RESULTS

The study included 151 participants (79 early- start group, 72 late-start group). The slope of RKF decline was slower after PD commencement (-2.69±0.18 mL/min/1.73m2/yr) compared to before PD commencement (-4.09±0.33 mL/min/1.73m2/yr; change in slope +1.19 mL/min/1.73m2/yr, 95% CI 0.48-1.90, p<0.001). In contrast, urine volume decline was faster after PD commencement (- 0.74±0.05 L/yr) compared to beforehand (-0.57±0.06 L/yr; change in slope -0.18 L/yr, 95%CI -0.34—-0.01, p=0.04). No differences were observed between the early- and late-start groups with respect to RKF decline, urine volume decline or time to anuria.

CONCLUSION

Commencement of PD was associated with a slower decline of RKF compared to the pre-dialysis period.

 


Figure 1. Trend of glomerular filtration rate (normalized to BSA) over time. Gray lines: individual patient measurements; black lines: predicted slopes in the pre- and post-dialysis initiation periods.

c Copyright 2020 -2021 American Society of Nephrology. Reproduced with permission.
All ASN abstracts from the 2020 Annual Meeting are available at this link and also are archived in .pdf form at ASN-Online.org

Disclaimer: Abstracts often have errors, both typographical and otherwise. This posting is an electronic translation of submitted abstracts which has not been verified against the original submitted abstract nor with the authors for accuracy. As a result, there may be errors, especially with regard to drug doses, but not limited to these. Abstracts undergo only limited review, and data often are changed as a result of the peer review process, so their reliability is less than manuscripts published in peer-reviewed journals. In using these summaries, you are agreeing that you are aware of these limitations.

The materials are provided on an as-is basis without any warranty of any kind, either express or implied. In addition to errors, the information presented may be incomplete or outdated. The information contained is not intended nor recommended as a substitute for professional medical advice. You are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device to be used or drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other health care professional, relying on independent experience and knowledge of the patient, to determine drug, disease, and the best treatment for the patient.

To the fullest extent permitted by law, HDCN, ASN and their affiliates and suppliers disclaim all warranties, express or implied, including, but not limited to, any warranty of merchantability, non- infringement or fitness for a particular purpose.

In no event shall HDCN, ASN, or their affiliates or suppliers be liable for any damages whatsoever (including, but not limited to, direct, indirect, incidental, consequential, punitive or exemplary damages, or any damages for loss of profits, use, data, goodwill or other intangibles) arising from or in any way relating to these terms, the materials, or any information, goods or services obtained from or referred to in the materials, whether based on warranty, contract, tort (including, but not limited to, negligence), or any other legal theory, and whether or not any or all of the limited entities is advised of the possibility of such damages.